The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa—A Narrative Review - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Exploring Inflammatory Biomarkers' Impact on Disease Severity and Treatment Efficacy in Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa: A Comprehensive Review

  • By

  • Julia Alicja Lewandowska

  • Agnieszka Owczarczyk–Saczonek

  • May 19, 2026

Share

Original Source(s)

The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa—A Narrative Review

  • by Julia Alicja Lewandowska, Agnieszka Owczarczyk–Saczonek

  • May 19, 2026

Related Content

Reorganization and functional divergence of the CD4+ memory T cell compartment in hidradenitis suppurativa

Understanding Social Drivers of Health Among US Adults with Psoriasis from Different Races and Ethnicities

Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”